Cargando…

Antibodies Contributing to Focal Epilepsy Signs and Symptoms Score

OBJECTIVE: Diagnosing autoimmune encephalitis (AIE) is difficult in patients with less fulminant diseases such as epilepsy. However, recognition is important, as patients require immunotherapy. This study aims to identify antibodies in patients with focal epilepsy of unknown etiology, and to create...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Bruijn, Marienke A. A. M., Bastiaansen, Anna E. M., Mojzisova, Hana, van Sonderen, Agnes, Thijs, Roland D., Majoie, Marian J. M., Rouhl, Rob P. W., van Coevorden‐Hameete, Marleen H., de Vries, Juna M., Muñoz Lopetegi, Amaia, Roozenbeek, Bob, Schreurs, Marco W. J., Sillevis Smitt, Peter A. E., Titulaer, Maarten J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048471/ https://www.ncbi.nlm.nih.gov/pubmed/33427313 http://dx.doi.org/10.1002/ana.26013

Ejemplares similares

Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA(B)R encephalitis
por: de Bruijn, Marienke A.A.M., et al.
Publicado: (2019)

Autoimmune Encephalitis Resembling Dementia Syndromes
por: Bastiaansen, Anna E.M., et al.
Publicado: (2021)

Detection and Characterization of Autoantibodies to Neuronal Cell-Surface Antigens in the Central Nervous System
por: van Coevorden-Hameete, Marleen H., et al.
Publicado: (2016)

Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment
por: Muñoz-Lopetegi, Amaia, et al.
Publicado: (2020)

Pediatric autoimmune encephalitis: Recognition and diagnosis
por: de Bruijn, Marienke A.A.M., et al.
Publicado: (2020)

Plasticity-related gene 5: A novel surface autoantigen in paraneoplastic cerebellar degeneration
por: van Coevorden-Hameete, Marleen H., et al.
Publicado: (2015)

The expanded clinical spectrum of anti-GABA(B)R encephalitis and added value of KCTD16 autoantibodies
por: van Coevorden-Hameete, Marleen H, et al.
Publicado: (2019)

Mimics of Autoimmune Encephalitis: Validation of the 2016 Clinical Autoimmune Encephalitis Criteria
por: Van Steenhoven, Robin W., et al.
Publicado: (2023)

Phase II trial of natalizumab for the treatment of anti-Hu associated paraneoplastic neurological syndromes
por: Bastiaansen, Anna E M, et al.
Publicado: (2021)

Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitis
por: de Bruijn, Marienke A.A.M., et al.
Publicado: (2018)

Antibodies to TRIM46 are associated with paraneoplastic neurological syndromes
por: van Coevorden‐Hameete, Marleen H., et al.
Publicado: (2017)

Pathologically confirmed autoimmune encephalitis in suspected Creutzfeldt-Jakob disease
por: Maat, Peter, et al.
Publicado: (2015)

Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy
por: Bastiaansen, Anna E.M., et al.
Publicado: (2021)

Predictive Value of Serum Neurofilament Light Chain Levels in Anti-NMDA Receptor Encephalitis
por: Brenner, Juliette, et al.
Publicado: (2023)

Standardized test for anti-Tr/DNER in patients with paraneoplastic cerebellar degeneration
por: Probst, Christian, et al.
Publicado: (2015)

A database application for pre-processing, storage and comparison of mass spectra derived from patients and controls
por: Titulaer, Mark K, et al.
Publicado: (2006)

Label-free peptide profiling of Orbitrap™ full mass spectra
por: Titulaer, Mark K, et al.
Publicado: (2011)

Antibodies Associated With Autoimmune Encephalitis in Patients With Presumed Neurodegenerative Dementia
por: Bastiaansen, Anna E.M., et al.
Publicado: (2023)

Skin lesions in children admitted to the paediatric intensive care unit: an observational study
por: Sillevis Smitt, J. Henk, et al.
Publicado: (2011)

Proteomics Comparison of Cerebrospinal Fluid of Relapsing Remitting and Primary Progressive Multiple Sclerosis
por: Stoop, Marcel P., et al.
Publicado: (2010)

Immune Repertoire after Immunization As Seen by Next-Generation Sequencing and Proteomics
por: VanDuijn, Martijn M., et al.
Publicado: (2017)

A software application for comparing large numbers of high resolution MALDI-FTICR MS spectra demonstrated by searching candidate biomarkers for glioma blood vessel formation
por: Titulaer, Mark K, et al.
Publicado: (2008)

Grsf1-Induced Translation of the SNARE Protein Use1 Is Required for Expansion of the Erythroid Compartment
por: Nieradka, Andrzej, et al.
Publicado: (2014)

Mitochondrial Neurogastrointestinal Encephalomyopathy Caused by Thymidine Phosphorylase Enzyme Deficiency: From Pathogenesis to Emerging Therapeutic Options
por: Yadak, Rana, et al.
Publicado: (2017)

An antibody-based biomarker discovery method by mass spectrometry sequencing of complementarity determining regions
por: Dekker, Lennard J. M., et al.
Publicado: (2010)

Lack of B and T cell reactivity towards IDH1(R132H) in blood and tumor tissue from LGG patients
por: Weenink, Bas, et al.
Publicado: (2019)

The effect of dexamethasone on the microenvironment and efficacy of checkpoint inhibitors in glioblastoma: a systematic review
por: Swildens, Kyra X, et al.
Publicado: (2022)

The use of eye‐movement recording in patients with anti‐Hu antibody–associated paraneoplastic neurological syndromes to objectively determine extent and course of disease
por: Janssen, Malou, et al.
Publicado: (2021)

Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer
por: Bastiaansen, Anna E. M., et al.
Publicado: (2020)

Novel Antibody–Peptide Binding Assay Indicates Presence of Immunoglobulins against EGFR Phospho-Site S1166 in High-Grade Glioma
por: Zeneyedpour, Lona, et al.
Publicado: (2022)

Gene expression profiles of gliomas in formalin-fixed paraffin-embedded material
por: Gravendeel, L A M, et al.
Publicado: (2012)

Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives
por: Weenink, Bas, et al.
Publicado: (2020)

ABO blood group distributions in multiple sclerosis patients from Basque Country; O(-) as a protective factor
por: Lopetegi, Itziar, et al.
Publicado: (2019)

Hospital Variation in Time to Endovascular Treatment for Ischemic Stroke: What Is the Optimal Target for Improvement?
por: den Hartog, Sanne J., et al.
Publicado: (2021)

Brain stem encephalitis is a rare complication of COVID-19
por: Shamier, Marc C., et al.
Publicado: (2023)

Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study
por: Taal, Walter, et al.
Publicado: (2012)

No evidence for circulating HuD-specific CD8(+) T cells in patients with paraneoplastic neurological syndromes and Hu antibodies
por: de Beukelaar, Janet W., et al.
Publicado: (2007)

Added Value of a Blinded Outcome Adjudication Committee in an Open-Label Randomized Stroke Trial
por: van der Ende, Nadinda A.M., et al.
Publicado: (2021)

Low-grade glioma harbors few CD8 T cells, which is accompanied by decreased expression of chemo-attractants, not immunogenic antigens
por: Weenink, Bas, et al.
Publicado: (2019)

Pazopanib exposure decreases as a result of an ifosfamide-dependent drug–drug interaction: results of a phase I study
por: Hamberg, P, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_47581e4hf0qsai64p8ke2hempo